A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
Clinical trial NCT06926660 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06926660
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-18
- Primary completion
- 2026-08-20
- Enrollment
- 492
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.